This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Feb 10;65(5):514-5.

doi: 10.1016/j.jacc.2014.09.091.

Some caveats about QRS duration in patients receiving cardiac resynchronization therapy

PMID: 25660933
DOI: 10.1016/j.jacc.2014.09.091

Free article

Comment

Some caveats about QRS duration in patients receiving cardiac resynchronization therapy

John E Madias. J Am Coll Cardiol. 2015.

Free article

. 2015 Feb 10;65(5):514-5.

doi: 10.1016/j.jacc.2014.09.091.

Author

PMID: 25660933
DOI: 10.1016/j.jacc.2014.09.091

No abstract available

PubMed Disclaimer

Comment in

Reply: Some caveats about QRS duration in patients receiving cardiac resynchronization therapy.
Zusterzeel R, Caños DA, Sanders WE, Selzman KA, Ponirakis A, Varosy PD, Strauss DG. Zusterzeel R, et al. J Am Coll Cardiol. 2015 Feb 10;65(5):515. doi: 10.1016/j.jacc.2014.10.062. J Am Coll Cardiol. 2015. PMID: 25660935 No abstract available.

Comment on

Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR.
Zusterzeel R, Curtis JP, Caños DA, Sanders WE, Selzman KA, Piña IL, Spatz ES, Bao H, Ponirakis A, Varosy PD, Masoudi FA, Strauss DG. Zusterzeel R, et al. J Am Coll Cardiol. 2014 Sep 2;64(9):887-94. doi: 10.1016/j.jacc.2014.06.1162. J Am Coll Cardiol. 2014. PMID: 25169173

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information